This pipeline maps genes, with mutation or copy number alteration AND this alteration is highly correlated with mRNA expression, to pathways curated in the KEGG and BIOCARTA databases. It identifies pathways significantly enriched with these genes. The pipeline also identifies pathways significantly enriched with marker genes of each expression subtype of cancer.
genes with mutation: identified by the Mutation_Significance pipeline
genes with copy number alteration: identified by the CopyNumber_Gistic2 pipeline
correlation between copy number and mRNA expression: identified by the Correlate_CopyNumber_vs_mRNA pipeline
marker genes and expression subtypes: identified by the mRNAConsensusClustering pipeline
There are 20 genes with significant mutation (Q value <= 0.1) and 187 genes with significant copy number alteration (Q value <= 0.25). The identified marker genes (Q value <= 0.01 or within top 2000) are 2000 for subtype 1, 2000 for subtype 2, 2000 for subtype 3. Pathways significantly enriched with these genes (Q value <= 0.01) are identified :
0 pathways significantly enriched with genes with copy number alteration or mutation.
9 pathways significantly enriched with marker genes of gene expression subtype 1
12 pathways significantly enriched with marker genes of gene expression subtype 2
18 pathways significantly enriched with marker genes of gene expression subtype 3
Pathway | Nof Genes | Nof CNV_Mut | Enrichment | P value | Q value |
---|---|---|---|---|---|
BIOCARTA_RACCYCD_PATHWAY | 26 | 4 | 4 | 0.0001 | 0.038 |
BIOCARTA_CHREBP2_PATHWAY | 44 | 4 | 3.3 | 0.0008 | 0.042 |
BIOCARTA_TEL_PATHWAY | 18 | 3 | 4.1 | 0.0007 | 0.042 |
BIOCARTA_ARF_PATHWAY | 17 | 3 | 4.2 | 0.0006 | 0.042 |
KEGG_PANCREATIC_CANCER | 70 | 5 | 2.8 | 0.0006 | 0.042 |
AKT1,CCNE1,RAC1,RB1
PPP2R5D,YWHAQ,PPP2R5E,PPP2R2A
RB1,AKT1,KRAS
POLR1C,RB1,RAC1
AKT1,RB1,KRAS,RAC1,BRCA2
Pathway | Nof Genes | Nof Marker | Enrichment | P value | Q value |
---|---|---|---|---|---|
KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION | 272 | 56 | 1.2 | 0 | 0 |
BIOCARTA_MAPK_PATHWAY | 87 | 20 | 1.3 | 0.0001 | 0.004 |
KEGG_MAPK_SIGNALING_PATHWAY | 267 | 44 | 0.87 | 0 | 0.004 |
KEGG_WNT_SIGNALING_PATHWAY | 151 | 28 | 1 | 0.0001 | 0.0065 |
KEGG_ENDOCYTOSIS | 183 | 31 | 0.94 | 0.0002 | 0.0077 |
ADORA3,S1PR2,HTR1A,CHRNA9,GRIN2D,HTR1D,CHRNA2,SSTR4,HTR7,MC2R,PPYR1,HCRTR1,ADRB3,PTH2R,GH2,GLRA1,GLRA2,HTR5A,GRM1,GRM4,GRM8,NPFFR1,MC3R,OPRL1,GRIA4,PLG,GRIA2,HTR2C,F2RL3,GRIK1,GRIK3,GABRB1,GHRHR,GALR2,GLP1R,ADCYAP1R1,DRD5,P2RY6,GABRA2,GABRA1,GABRA4,GABRA3,GRIN1,GPR35,P2RX6,P2RX2,ADRA1B,ADRA1D,GABRG2,FSHR,CHRM5,FSHB,TSHB,PRLR,MLNR,OPRD1
MEF2A,DAXX,PAK1,RAPGEF2,MAP2K7,MAP2K6,MAP2K5,BRAF,MAP4K3,MAPK1,MAPK6,MAPK4,MAP3K10,MAP3K13,MKNK2,MAPKAPK3,ELK1,MAP4K1,MAP3K3,PSG1
MOS,RAPGEF2,MAP2K7,MAP2K6,MAP2K5,BRAF,MAPK1,PLA2G2A,CACNB1,HSPA1A,HSPA1L,RAC3,TAOK2,FGF5,DAXX,MAPT,MAP3K13,GADD45A,MKNK2,CHP,RASA1,DUSP4,FGF14,FGF12,RRAS,FGF22,DDIT3,MAP4K3,STMN1,MAPKAPK3,MAP4K1,ELK1,CACNA2D1,CACNA1I,NR4A1,CACNA2D2,RAP1A,CACNA1A,PAK1,AKT2,TNFRSF1A,HSPA2,MAP3K3,HSPA6
PPP2R5B,PPP2R5A,WNT2,WNT1,WNT3,WNT10B,RAC3,DVL2,SFRP1,RHOA,FRAT2,PLCB1,CTBP2,SUMO1,WNT16,APC2,CHP,NFATC3,CAMK2A,APC,CSNK1A1,FZD9,FZD3,FZD7,DKK4,DKK1,LRP6,LRP5
HLA-C,HLA-F,ERBB4,HSPA1A,CHMP2B,HSPA1L,ADRB3,IQSEC1,AP2M1,IQSEC2,PARD6A,GRK4,SMURF2,CLTA,LDLR,RAB5C,IL8RA,PIP5K1C,PIP5K1A,RAB5A,EPN1,HSPA2,HSPA6,IL2RG,EHD1,DNM3,IL2RA,DNM1L,ARAP2,DNM1,RNF41
Pathway | Nof Genes | Nof Marker | Enrichment | P value | Q value |
---|---|---|---|---|---|
KEGG_OXIDATIVE_PHOSPHORYLATION | 133 | 28 | 1.5 | 0 | 0 |
KEGG_ENDOCYTOSIS | 183 | 39 | 1.3 | 0 | 0 |
KEGG_ALZHEIMERS_DISEASE | 167 | 32 | 1.2 | 0 | 0.0002 |
KEGG_SPLICEOSOME | 126 | 25 | 1.3 | 0 | 0.0004 |
KEGG_LYSOSOME | 121 | 26 | 1.3 | 0 | 0.0004 |
ATP6AP1,NDUFAB1,ATP6V1B1,COX8A,PPA1,NDUFV2,COX11,UQCRC1,UQCRFS1,UQCRQ,NDUFS3,NDUFS2,ATP5H,COX17,NDUFC2,COX4I1,ATP6V1F,NDUFB3,NDUFB5,NDUFB6,NDUFB7,ATP5G3,NDUFB1,ATP5F1,SDHA,SDHB,ATP6V0A1,ATP5A1
CHMP5,VPS4B,ITCH,ARRB2,PDCD6IP,CHMP2A,ARFGAP3,ARFGAP2,STAM2,ADRBK2,HSPA1A,ARF6,TRAF6,PARD6A,PARD6B,CBLC,CBLB,GRK6,SMURF1,CLTB,IL8RB,AP2B1,UNC45A,AGAP1,LDLRAP1,RAB11FIP5,RAB11FIP3,EPN2,PARD3,USP8,IGF1R,HSPA6,RAB11A,EHD3,EHD4,FAM125B,DNM1L,DNM1,RNF41
SNCA,NDUFAB1,FAS,HSD17B10,COX8A,NDUFV2,UQCRC1,UQCRFS1,UQCRQ,PLCB3,CASP7,CASP8,NDUFS3,NDUFS2,ATP5H,NDUFC2,COX4I1,NDUFB3,NDUFB5,NDUFB6,NDUFB7,ATP5G3,NDUFB1,TNFRSF1A,PPP3CA,ATP5F1,NAE1,SDHA,SDHB,GSK3B,ATP5A1,CALM1
NCBP1,SFRS6,SFRS7,RBM8A,SFRS9,SFRS3,HNRNPC,SNRPF,SNRPE,NHP2L1,HSPA1A,HNRNPM,HNRNPK,RBMX,HNRNPA1,PPIH,CRNKL1,PRPF31,SR140,SF3B5,SF3B3,PRPF8,USP39,HSPA6,RBM25
ATP6AP1,NPC1,ACP5,ACP2,CTSA,PPT1,CTSL1,ENTPD4,LAPTM4A,DNASE2,CLTB,ASAH1,TPP1,CTSK,CTSE,CTSC,CTSB,GNPTAB,AP3M2,GBA,CEL,PSAP,GLA,ARSA,ATP6V0A1,GGA2
Pathway | Nof Genes | Nof Marker | Enrichment | P value | Q value |
---|---|---|---|---|---|
KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION | 272 | 63 | 1.4 | 0 | 0 |
KEGG_PATHWAYS_IN_CANCER | 328 | 57 | 0.94 | 0 | 0.0001 |
WNT_SIGNALING | 89 | 22 | 1.4 | 0 | 0.0007 |
KEGG_MAPK_SIGNALING_PATHWAY | 267 | 45 | 0.89 | 0 | 0.0009 |
KEGG_WNT_SIGNALING_PATHWAY | 151 | 30 | 1.1 | 0 | 0.0009 |
LHCGR,S1PR2,AGTR2,HTR1A,S1PR1,LTB4R,GRIN2C,CHRNA5,GRID2,CHRNA2,HTR1E,HTR4,SSTR5,CRHR2,F2,HCRTR2,CHRNB3,OPRM1,GLRA3,GHR,GRM1,GRM3,GRM2,GRM8,GRM7,NPY2R,NPFFR1,GRIA4,GRIA2,GRIA1,MC4R,THRA,GRIK1,GABRB2,GRIK3,GABRB1,SCTR,GALR3,GALR2,GABRR1,GLP1R,DRD1,DRD2,DRD5,ADRA2A,GABRA1,GABRA4,GABRA3,P2RX7,P2RX6,P2RX2,ADRA1B,ADRA1D,TACR2,GABBR1,PRL,FSHR,FSHB,TSHB,DHX15,GLRB,MLNR,CHRNA10
PTGS2,PGF,SHH,CTNNB1,CTNNA3,VEGFB,MAPK1,JUN,LAMC2,LAMB4,KRAS,DVL3,MAP2K1,SMAD2,CBLB,LAMA3,LAMA5,NTRK1,FGF5,MITF,PTEN,FGF3,CTBP1,TFG,FZD9,BIRC5,MAPK10,FZD6,RASSF1,FGF18,CDKN2A,WNT3,RET,FGF21,FGFR2,WNT5A,FGFR1,WNT5B,RBX1,TRAF4,AXIN1,EPAS1,ITGA3,IKBKG,MTOR,HSP90AB1,E2F2,MAX,PAX8,AKT2,PRKCB,CRKL,WNT11,GSTP1,EGLN3,CEBPA,COL4A1
CTNNB1,WNT3,AES,FOSL1,CTBP1,CSNK1G1,CTNNBIP1,CCND2,JUN,PYGO1,WNT11,FSHB,WNT5A,WNT5B,HPRT1,T,AXIN1,GPI,FZD6,CSNK1D,WIF1,LRP5
MOS,MAP2K7,MAPK1,JUN,PLA2G2A,MAPK7,PLA2G2E,PLA2G2D,CACNB2,KRAS,MAP2K1,TAOK2,PLA2G4A,NTRK1,FGF5,FGF3,ECSIT,FLNA,GADD45G,GADD45A,MAP3K12,MAP3K11,PLA2G12A,PPP3CC,GPI,MAPK10,MAPK13,RPS6KA2,DUSP8,FGF18,FGF21,MAP4K4,RASGRF1,PPP5C,FGFR2,FGFR1,MRAS,MAP4K1,ELK4,IKBKG,CACNA1A,MAX,AKT2,PRKCB,CRKL
PPP2R5B,PPP2R5A,CTNNB1,WNT3,JUN,WNT5A,WNT5B,RBX1,AXIN1,DVL3,SMAD2,SFRP5,WIF1,FOSL1,PLCB2,CTBP1,PRKCB,CTNNBIP1,CCND2,WNT11,CER1,PPP3CC,NFATC1,FZD9,GPI,MAPK10,DKK4,FZD6,LRP5,TBL1Y
Let genes with copy number alteration or mutation be query genes. Let marker genes of specific identified subtypes be query genes. The Enrichment is calculated as:
-
Enrichment = log2 (# of query genes in the pathway/# No of query genes) - log2 (# of genes in the pathway/# of human genes)
The statistical signficance of the pathways that are enriched with genes with copy number alteration or mutation, and the pathways that are enriched with markers genes of specific identified subtypes is measured by P value.
-
P value = Fisher exact P value
The Q value is for adjusting P value for multiple testing. A public available R package is used to calculate the Q value.
This is an experimental feature. The full results of the analysis summarized in this report can be downloaded from the TCGA Data Coordination Center.